Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Regenxbio Inc (RGNX)

Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Regenxbio: Q3 Earnings Snapshot AP - Wed Nov 6, 4:02PM CST

Regenxbio: Q3 Earnings Snapshot

RGNX : 9.18 (-4.67%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth FinancialNewsMedia - Wed Sep 4, 8:15AM CDT

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

SBFM : 2.12 (-2.75%)
NVAX : 8.04 (-0.25%)
RGNX : 9.18 (-4.67%)
BNTX : 108.23 (+5.96%)
ABBV : 171.73 (+2.37%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth GlobeNewswire - Wed Sep 4, 8:15AM CDT

SBFM : 2.12 (-2.75%)
NVAX : 8.04 (-0.25%)
RGNX : 9.18 (-4.67%)
BNTX : 108.23 (+5.96%)
ABBV : 171.73 (+2.37%)
Regenxbio: Q2 Earnings Snapshot AP - Thu Aug 1, 3:46PM CDT

Regenxbio: Q2 Earnings Snapshot

RGNX : 9.18 (-4.67%)
Regenxbio: Q1 Earnings Snapshot AP - Wed May 8, 3:44PM CDT

Regenxbio: Q1 Earnings Snapshot

RGNX : 9.18 (-4.67%)
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling? Motley Fool - Wed Mar 13, 7:00AM CDT

The threat is still emerging, but it could be significant.

SRPT : 110.50 (-0.32%)
RGNX : 9.18 (-4.67%)
Regenxbio: Q4 Earnings Snapshot AP - Tue Feb 27, 3:32PM CST

Regenxbio: Q4 Earnings Snapshot

RGNX : 9.18 (-4.67%)
Regenxbio: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Regenxbio: Q3 Earnings Snapshot

RGNX : 9.18 (-4.67%)
REGENXBIO to Participate in the Jefferies CNS/Neuro Summit PR Newswire - Thu Oct 5, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Jefferies CNS/Neuro Summit on Thursday, October 12, 2023. Jefferies...

RGNX : 9.18 (-4.67%)
REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNE™ Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society PR Newswire - Tue Oct 3, 2023

RGX-202, a potential one-time AAV Therapeutic for the treatment of Duchenne that includes an optimized transgene for a novel microdystrophin, continues to be...

RGNX : 9.18 (-4.67%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - 1 minute ago
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot